QS Batterymarch Financial Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.82M Sell
342,721
-30,050
-8% -$632K 0.18% 164
2014
Q2
$8.5M Sell
372,771
-38,750
-9% -$690K 0.22% 132
2014
Q1
$5.29M Sell
411,521
-9,650
-2% -$138K 0.11% 277
2013
Q4
$5.75M Sell
421,171
-9,840
-2% -$117K 0.12% 263
2013
Q3
$4.78M Buy
431,011
+92,910
+27% +$925K 0.1% 306
2013
Q2
$2.79M Buy
+338,101
New +$2.84M 0.05% 464

Other funds holding RGEN

QS Batterymarch Financial Management's RGEN Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Repligen (RGEN) stake by 8.1% in Q3 2014, selling an estimated $632K and leaving 342,721 shares worth $6.82M. The position accounts for 0.18% of the portfolio, ranked #164.

QS Batterymarch Financial Management first reported a position in RGEN in Q2 2013 and has held it in 6 quarters since. The position peaked at $8.5M in Q2 2014. 164 funds tracked by Wall St. Rank hold RGEN as of Q3 2014.

  • QS Batterymarch Financial Management held 342,721 shares of Repligen worth $6.82M as of Q3 2014.
  • QS Batterymarch Financial Management sold 30,050 Repligen shares in Q3 2014, an estimated $632K.
  • Repligen made up 0.18% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #164 holding.
  • QS Batterymarch Financial Management first reported a position in Repligen in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Repligen position peaked at $8.5M in Q2 2014.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.